Suppr
超能文献

The cost of diabetes Type II in Europe: the CODE-2 Study.

作者信息

Massi-Benedetti M

机构信息

Dipartimento di Medicina Interna, Università di Perugia, Via E. dal Pozzo, 06126 Perugia, Italy.

出版信息

Diabetologia. 2002 Jul;45(7):S1-4. doi: 10.1007/s00125-002-0860-3. Epub 2002 May 24.

DOI:10.1007/s00125-002-0860-3

PMID:12136404

Abstract

摘要

相似文献

The cost of diabetes Type II in Europe: the CODE-2 Study.

Diabetologia. 2002 Jul;45(7):S1-4. doi: 10.1007/s00125-002-0860-3. Epub 2002 May 24.

[The cost of type 2 diabetes: summary of the Cost of Diabetes in Europe-Type II study (CODE-2) and analysis of the situation in Belgium].

Rev Med Liege. 2005 May-Jun;60(5-6):278-84.

Revealing the cost of Type II diabetes in Europe.

Diabetologia. 2002 Jul;45(7):S5-12. doi: 10.1007/s00125-002-0858-x. Epub 2002 May 24.

[Costs of type 2 diabetes in Germany. Results of the CODE-2 study].

Dtsch Med Wochenschr. 2001 May 18;126(20):585-9. doi: 10.1055/s-2001-14102.

Coping with Type II diabetes: the patient's perspective.

Diabetologia. 2002 Jul;45(7):S18-22. doi: 10.1007/s00125-002-0861-2. Epub 2002 May 24.

[Costs involved in the early and late phases of diabetes mellitus].

Internist (Berl). 2007 Jul;48(7):708-14. doi: 10.1007/s00108-007-1875-0.

[Costs of long-term complications in type 2 diabetes patients in Germany. Results of the CODE-2 Study].

Med Klin (Munich). 2002 Dec 15;97(12):713-9. doi: 10.1007/s00063-002-1215-z.

[Evaluation of the burden of diabetes in Poland].

Pol Arch Med Wewn. 2001 Sep;106(3):867-73.

[Medical resources consumption of type 2 diabetics in France in 1998].

Diabetes Metab. 2000 May;26(3):225-31.

[Economic significance of diabetes in Germany].

Med Monatsschr Pharm. 1999 Mar;22(3):65-6.

引用本文的文献

Impact of Pharmacist Educational Intervention on Costs of Medication with Improved Clinical Outcomes for Diabetic Patients in Various Tertiary Care Hospitals in Malaysia: A Randomized Controlled Trial.

Healthcare (Basel). 2025 Apr 14;13(8):901. doi: 10.3390/healthcare13080901.

Cost-effectiveness of prevention program for type 2 diabetes mellitus in high risk patients in the Republic of Srpska, Bosnia and Herzegovina.

Libyan J Med. 2025 Dec;20(1):2437226. doi: 10.1080/19932820.2024.2437226. Epub 2024 Dec 15.

Effectiveness of using technology as health education tool among diabetes patients in South India: A comparative analysis and community based intervention.

J Family Med Prim Care. 2022 Aug;11(8):4667-4670. doi: 10.4103/jfmpc.jfmpc_2081_21. Epub 2022 Aug 30.

The Effect of Nutrition Education Using MyPlate on Lipid Profiles, Glycemic Indices, and Inflammatory Markers in Diabetic Patients.

Clin Nutr Res. 2022 Jul 25;11(3):171-182. doi: 10.7762/cnr.2022.11.3.171. eCollection 2022 Jul.

Acute Effects of Cocoa Flavanols on Blood Pressure and Peripheral Vascular Reactivity in Type 2 Diabetes Mellitus and Essential Hypertension.

Nutrients. 2022 Jun 28;14(13):2692. doi: 10.3390/nu14132692.

Analysis of the Impact of Disease Acceptance, Demographic, and Clinical Variables on Adherence to Treatment Recommendations in Elderly Type 2 Diabetes Mellitus Patients.

Int J Environ Res Public Health. 2021 Aug 16;18(16):8658. doi: 10.3390/ijerph18168658.

Prevalence of overweight/obesity and its associated factors among a sample of Moroccan type 2 diabetes patients.

Afr Health Sci. 2021 Mar;21(1):23-31. doi: 10.4314/ahs.v21i1.5.

Acute Effects of Cocoa Flavanols on Blood Pressure and Peripheral Vascular Reactivity in Type 2 Diabetes Mellitus and Essential Hypertension: A Protocol for an Acute, Randomized, Double-Blinded, Placebo-Controlled Cross-Over Trial.

Front Cardiovasc Med. 2021 Mar 15;8:602086. doi: 10.3389/fcvm.2021.602086. eCollection 2021.

Measuring Quality of Life in Type 2 Diabetic Patients at the Al-Wazarat Healthcare Center in Riyadh.

Cureus. 2019 Dec 27;11(12):e6474. doi: 10.7759/cureus.6474.

Type 2 diabetes mellitus in Bangladesh: a prevalence based cost-of-illness study.

BMC Health Serv Res. 2019 Aug 27;19(1):601. doi: 10.1186/s12913-019-4440-3.

本文引用的文献

The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group.

Diabetes Care. 2000 Nov;23(11):1619-29. doi: 10.2337/diacare.23.11.1619.

The progressive cost of complications in type 2 diabetes mellitus.

Arch Intern Med. 1999 Sep 13;159(16):1873-80. doi: 10.1001/archinte.159.16.1873.

Diabetes epidemiology as a tool to trigger diabetes research and care.

Diabetologia. 1999 May;42(5):499-518. doi: 10.1007/s001250051188.

Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study.

Diabetes Care. 1999 Apr;22(4):562-8. doi: 10.2337/diacare.22.4.562.

Type 2 diabetes mellitus: the grand overview.

Diabet Med. 1998;15 Suppl 4:S4-7. doi: 10.1002/(sici)1096-9136(1998120)15:4+<s4::aid-dia735>3.3.co;2-t.

The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insulin-Dependent Diabetes Mellitus.

Diabetes Care. 1998 Oct;21(10):1720-5. doi: 10.2337/diacare.21.10.1720.

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Lancet. 1998 Sep 12;352(9131):854-65.

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Lancet. 1998 Sep 12;352(9131):837-53.

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group.

BMJ. 1998 Sep 12;317(7160):713-20.

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

BMJ. 1998 Sep 12;317(7160):703-13.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

The cost of diabetes Type II in Europe: the CODE-2 Study.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译